BioCentury
ARTICLE | Financial News

Acorda amends IPO

December 1, 2003 8:00 AM UTC

Neurology company Acorda (Hawthorne, N.Y.) -- which originally filed to raise up to $75 million on Sept. 30 -- updated its IPO filing and now hopes to sell 4.8 million shares at $12-$14. A $13 share price would raise $62.4 million for the company and give it a post-money valuation of $271.2 million. The offering, which has a 720,000 share overallotment, will be underwritten by Banc of America Securities; Lazard; U.S. Bancorp Piper Jaffray; and RBC Capital Markets. ...